Defunct Company
Total Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
235
NCT01183910
A Novel Oral Natural Extract for the Treatment of Senile Purpura
Phase: N/A
Role: Lead Sponsor
Start: Nov 30, 2008
Completion: Aug 31, 2011
NCT01301586
A Novel Combination Oral Agent to Treat Acne Vulgaris
Phase: Phase 1/2
Start: Nov 30, 2010
Completion: Sep 30, 2011
NCT01905631
Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated Pruritus
Phase: Phase 2
Role: Collaborator
Start: Jul 31, 2013
Completion: Sep 30, 2013
NCT04622033
Brodalumab in Palmoplantar Psoriasis
Phase: Phase 4
Start: Dec 1, 2020
Completion: May 31, 2022
NCT06488742
The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis
Start: Nov 1, 2023
Completion: Mar 20, 2025